-
Convalescent Serum Lines Up As First-Choice Treatment For Coronavirus
May 1, 2020 | Cormac Sheridan Antibodies from blood donated by people who recovered from the illness and hyper-immunoglobulins are becoming treatments of…
-
Jodi’s Journal: The Little Biotech Company That Could Beat COVID-19
By : Jodi Schwan, April 26, 2020 I deliberately put an attention-grabbing headline on this column, but it’s one I plan to back up with what I’m about to…
-
Behind SAB’s Rapid Response To COVID-19
BY SANDI WONG, ASSISTANT EDITOR | APR 24, 2020 | 6:48 PM CDT SAB had already been working with the U.S. Department of Defense to prepare its human…
-
HHS Facilitates Development Of Immunotherapies For COVID-19 Patients
April 13, 2020 In the race to identify and provide safe, effective treatments for hospitalized patients with COVID-19 , the U.S. Department of Health and…
-
BARDA, Department Of Defense, And SAb Biotherapeutics To Partner To Develop A Novel COVID-19 Therapeutic
A therapeutic to treat novel coronavirus disease 2019 (COVID-19) is moving forward in development through a partnership between BARDA, the Department of…
-
Sioux Falls Biotech Firm Rushing To Develop Coronavirus Treatment
March 12, 2020 By: Bart Pfankuch A Sioux Falls company — with its team of scientists and a herd of genetically engineered cows — is working quickly to…
-
Personal Impact, Global Influence, Right Here In South Dakota
February 18, 2020 Ever since moving to South Dakota in 2002 from Massachusetts, SAB Biotherapeutics has committed to growing the state’s economy,…
-
South Dakota Leads The Future Of Fighting Disease
December 13, 2019 By Michelle Cwach ‘09 A year after Shelly Brandsrud-Sprenger (’08, biology) gave birth to her first son, she was confronted with the…
-
SAB Adds To Executive Team With Industry Veteran
November 12, 2019 This paid piece is sponsored by South Dakota Biotech. A biopharmaceutical industry veteran is piloting SAB Biotherapeutics’…
-
S.D. Equity Partners Makes $1M Investment In SAB
Dec. 19, 2018 South Dakota Equity Partners has invested $1.05 million in Sioux Falls-based SAB Biotherapeutics, a biopharmaceutical development company.…
-
Here’s What’s Next For Massive Biotech Project
This piece is presented by South Dakota Biotech. A biotech campus that could include 10 buildings, more than 100,000 square feet and 400 animals will…
-
Cows Engineered With Human Genes Could Stop Our Next Disease Outbreak
Cattle that can crank out human antibodies are being tested as a first line of defense against infectious diseases. by Emily Mullin Oct 4, 2016 During…